文献速递脑血管病

联合敲除IL-4、IL-5、IL-9和IL-13不影响小鼠缺血性脑损伤

Combined Genetic Deletion of IL (Interleukin)-4, IL-5, IL-9, and IL-13 Does Not Affect Ischemic Brain Injury in Mice.
PubMed 文献 · Stroke · 2019-07-05

该研究在小鼠永久性大脑中动脉闭塞模型中,比较野生型与Th2细胞因子(IL-4、IL-5、IL-9、IL-13)联合敲除(4KO)小鼠的神经病理结局。结果发现4KO小鼠在24小时、7天和5周的梗死灶和神经元计数与野生型无差异,但小胶质细胞/巨噬细胞极化标志物在早期有改变。结论提示Th2细胞因子并非驱动缺血性脑损伤结局的必要神经免疫线索。

要点

  • 联合敲除IL-4、IL-5、IL-9、IL-13不影响小鼠永久性大脑中动脉闭塞后的梗死灶和神经元计数。
  • 4KO小鼠在24小时和7天时M1标志物(CD16/32、CD11b)表达降低,M2标志物(CD206、arginase1)表达升高。
  • 至5周时,脑萎缩、胶质瘢痕和胶原瘢痕在基因型间无差异。

核心结论

  • 联合敲除IL-4、IL-5、IL-9和IL-13不影响小鼠亚急性和慢性期缺血性脑卒中的神经病理反应。
  • Th2细胞因子并非驱动脑缺血结局的必要神经免疫线索。

研究设计与样本

  • 研究采用野生型和Th2细胞因子联合敲除(4KO)小鼠,行电凝法永久性大脑中动脉闭塞,随访至5周。
  • 神经病理结局在24小时(n=6)、7天(n=6)和5周(n=6-7)评估,包括缺血病灶、神经元计数、小胶质细胞/巨噬细胞标志物、脑萎缩、胶原沉积和GFAP免疫组化。
  • 部分基因表达在7天(n=6)检测。

主要发现

  • 4KO小鼠在7天和至5周时梗死灶和神经元计数与野生型无差异。
  • 缺血4KO小鼠24小时CD16/32表达低于野生型,7天CD11b和CD16/32表达低于野生型。
  • 4KO小鼠24小时CD206表达高于野生型,7天CD206和arginase1表达高于野生型,且CXCL9 mRNA增加。
  • 5周时脑萎缩、胶质瘢痕和胶原瘢痕在基因型间无差异。

关键数值与推荐

  • 4KO小鼠在24小时CD16/32表达降低,7天CD11b和CD16/32表达降低(与野生型比较)。
  • 4KO小鼠在24小时CD206表达升高,7天CD206和arginase1表达升高(与野生型比较)。
  • 4KO小鼠7天CXCL9 mRNA较野生型增加。

临床怎么用

  • 该结果提示靶向Th2细胞因子(IL-4、IL-5、IL-9、IL-13)联合通路未必能改变缺血性脑卒中的神经病理结局。
  • 小胶质细胞/巨噬细胞极化标志物的早期改变未转化为长期组织学获益,临床转化需谨慎解读极化指标。

局限性

  • 研究为小鼠永久性大脑中动脉闭塞模型,结论外推至人类缺血性脑卒中需谨慎。
  • 样本量较小(每组n=6-7),可能不足以检测微小差异。
  • 仅评估了联合敲除,未单独分析各细胞因子的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- After ischemic injury, microglia and infiltrated macrophages may acquire different polarization phenotypes promoting inflammation and injury (M1) or repair and protection (M2). There is evidence that immunomodulation, via type 2 helper T-cells (Th2) cytokines, exerts neuroprotection after ischemia. We investigated the consequences of simultaneous genetic deletion of Th2 cytokines (IL [interleukin]-4, IL-5, IL-9, IL-13) on the histopathologic outcome, microglia and infiltrated macrophages markers, and ischemic microenvironment at different time points after ischemic injury in mice subjected to permanent occlusion of the middle cerebral artery. Methods- Wild-type and Th2 cytokine-deficient mice (4KO) were subjected to permanent occlusion of the middle cerebral artery by electrocoagulation and followed up to 5 weeks after permanent occlusion of the middle cerebral artery. Neuropathologic outcome was assessed at 24 hours (n=6), 7 days (n=6), and 5 weeks (n=6-7) by examination of the ischemic lesion, neuronal count, microglia and infiltrated macrophages markers, brain atrophy, collagen deposition, and GFAP (glial fibrillary acidic protein) immunohistochemistry. Selected gene expression was investigated at 7 days (n=6). Results- 4KO mice showed no difference in lesion and neuronal count 7 days and up to 5 weeks after permanent occlusion of the middle cerebral artery compared with wild type. Ischemic 4KO mice had lower CD16/32 expression at 24 hours, lower CD11b and CD16/32 expression at 7 days than wild type. They had higher CD206 expression at 24 hours, higher CD206 and arginase1 at 7 days, and increased mRNA for CXCL9 (chemokine [C-X-C motif] ligand 9) compared with wild type. Additional histopathologic analysis, including brain atrophy, gliotic scar, and collagenous scar confirmed no difference between genotypes at 5 weeks. Conclusions- This study casts light on the proposed neuroprotective function of Th2 cytokines, showing that combined IL-4, IL-5, IL-9, IL-13 deletion does not affect the neuropathologic response to ischemic stroke in the subacute and chronic phases. Our findings indicate that Th2 cytokines are not an essential neuroimmunological cue able to drive the brain's ischemic outcome.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Perego C, Fumagalli S, Miteva K, et al. Combined Genetic Deletion of IL (Interleukin)-4, IL-5, IL-9, and IL-13 Does Not Affect Ischemic Brain Injury in Mice. Stroke. 2019. PMID: 31272316. doi:10.1161/STROKEAHA.119.025196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。